| Mrs Elizabeth Eversull, MD | |
|
5944 W Parker Rd, #400, Plano, TX 75093-6421 | |
| (972) 309-2021 | |
| (972) 309-2023 |
| Full Name | Mrs Elizabeth Eversull |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Pain Medicine |
| Location | 5944 W Parker Rd, Plano, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154380517 | NPI | - | NPPES |
| 176702201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | L5328 (Texas) | Secondary |
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | L5328 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elizabeth Eversull, MD Po Box 97, Boyce, LA 71409-0097 Ph: (972) 309-2021 | Mrs Elizabeth Eversull, MD 5944 W Parker Rd, #400, Plano, TX 75093-6421 Ph: (972) 309-2021 |
News Archive
Autism spectrum disorders (ASD), especially without an accompanying intellectual disability, were associated with greater risk for depression in young adulthood compared with the general population and siblings without ASD.
Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study.
Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.
Novartis announced today that the US Food and Drug Administration has approved Signifor long-acting release (LAR) (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
The American Hospital Association is lobbying the CMS Innovation Center to make it easier for accountable care organizations to earn Medicare bonuses and delay potential penalties as the agency looks to expand the initiative (Evans, 4/18).
› Verified 6 days ago
Dr. Sheena Bhuva, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6020 W Parker Rd Ste 200, Plano, TX 75093 Phone: 972-608-5000 | |
Maria C. Espejo, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 120, Plano, TX 75024 Phone: 217-779-5088 | |
Nayan Raman Patel, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6020 W Parker Rd, Suite 200, Plano, TX 75093 Phone: 972-608-5000 Fax: 972-608-5020 | |
Jocelyn Brooke Miller, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3700 W 15th St Ste 200b, Plano, TX 75075 Phone: 972-398-0261 | |
Dr. Manu Gupta, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3325 W Plano Pkwy, Plano, TX 75075 Phone: 972-379-0000 | |
Zair Shah, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2800 W 15th St, Plano, TX 75075 Phone: 972-612-9000 |